Fig. 4From: IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patientsThe comparison of anti-SARS-CoV-2 IgG APR and Ab levels in BCL (A and B) and DLBCL (C and D) patients treated with and without BTKiBack to article page